Warning letter
Natchez Animal Supply Company: warning letter of Oct 10, 2002
FDA warning letter UCM145165 · New Orleans District Office
Key facts
| Reference number | UCM145165 |
|---|---|
| Company | Natchez Animal Supply Company |
| Subject | Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated |
| Issue date | Oct 10, 2002 |
| Posted date | Oct 10, 2002 |
| Issuing office | New Orleans District Office |
| Product type | Drugs |
| CFR sections cited | 211.67(c), 2, 211.198, 211.22(d), 211.25(a), 211.56(c), 211.67(a), 211.67(b), 211.84(d)(1), 211.100(a), 211.122(a), 211.125(f) and 10 more |
| Country | 3 |
| Inspection city | Washington |
| Inspection ZIP | 39190 |
| Inspection start date | Aug 27, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: